BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7818534)

  • 1. Point mutation in the second phosphatase domain of CD45 abrogates tyrosine phosphatase activity.
    Ng DH; Maiti A; Johnson P
    Biochem Biophys Res Commun; 1995 Jan; 206(1):302-9. PubMed ID: 7818534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic activity of the Arabidopsis sulfurtransferase resides in the C-terminal domain but is boosted by the N-terminal domain and the linker peptide in the full-length enzyme.
    Burow M; Kessler D; Papenbrock J
    Biol Chem; 2002 Sep; 383(9):1363-72. PubMed ID: 12437129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of the membrane distal phosphatase domain of RPTPalpha reveals interdomain flexibility and an SH2 domain interaction region.
    Sonnenburg ED; Bilwes A; Hunter T; Noel JP
    Biochemistry; 2003 Jul; 42(26):7904-14. PubMed ID: 12834342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, expression and mutational analysis of SH-PTP2, human protein-tyrosine phosphatase.
    Bastien L; Ramachandran C; Liu S; Adam M
    Biochem Biophys Res Commun; 1993 Oct; 196(1):124-33. PubMed ID: 8216283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphatase domains of LAR, CD45, and PTP1B: structural correlations with peptide-based inhibitors.
    Glover NR; Tracey AS
    Biochem Cell Biol; 2000; 78(1):39-50. PubMed ID: 10735562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of CD45 extracellular domain sequences from divergent vertebrate species suggests the conservation of three fibronectin type III domains.
    Okumura M; Matthews RJ; Robb B; Litman GW; Bork P; Thomas ML
    J Immunol; 1996 Aug; 157(4):1569-75. PubMed ID: 8759740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of restricted isoform expression and tyrosine phosphatase activity of CD45 in murine dendritic cells.
    Haidl ID; Ng DH; Rothenberger S; Johnson P; Jefferies WA
    Eur J Immunol; 1995 Dec; 25(12):3370-4. PubMed ID: 8566025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate specificities of catalytic fragments of protein tyrosine phosphatases (HPTP beta, LAR, and CD45) toward phosphotyrosylpeptide substrates and thiophosphotyrosylated peptides as inhibitors.
    Cho H; Krishnaraj R; Itoh M; Kitas E; Bannwarth W; Saito H; Walsh CT
    Protein Sci; 1993 Jun; 2(6):977-84. PubMed ID: 8318901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha.
    Buist A; Zhang YL; Keng YF; Wu L; Zhang ZY; den Hertog J
    Biochemistry; 1999 Jan; 38(3):914-22. PubMed ID: 9893986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification, and characterization of rat protein tyrosine phosphatase eta catalytic domain.
    Santos MA; Santos SM; Matozo HC; Portugal RV; Iuliano R; Fusco A; Polikarpov I
    Protein Expr Purif; 2005 May; 41(1):113-20. PubMed ID: 15802228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of Ca(2+)/calmodulin-dependent protein kinase phosphatase (CaMKP).
    Tada Y; Nimura T; Sueyoshi N; Ishida A; Shigeri Y; Kameshita I
    Arch Biochem Biophys; 2006 Aug; 452(2):174-85. PubMed ID: 16844074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of integrin-mediated T cell adhesion by the transmembrane protein tyrosine phosphatase CD45.
    Shenoi H; Seavitt J; Zheleznyak A; Thomas ML; Brown EJ
    J Immunol; 1999 Jun; 162(12):7120-7. PubMed ID: 10358156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substitution of two variant residues in the protein tyrosine phosphatase-like PTP35/IA-2 sequence reconstitutes catalytic activity.
    Magistrelli G; Toma S; Isacchi A
    Biochem Biophys Res Commun; 1996 Oct; 227(2):581-8. PubMed ID: 8878556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
    Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
    Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation.
    Huyer G; Ramachandran C
    Biochemistry; 1998 Mar; 37(9):2741-7. PubMed ID: 9485424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed mutagenesis of a regulatory site of Escherichia coli ADP-glucose pyrophosphorylase: the role of residue 336 in allosteric behavior.
    Meyer CR; Bork JA; Nadler S; Yirsa J; Preiss J
    Arch Biochem Biophys; 1998 May; 353(1):152-9. PubMed ID: 9578610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein lipase: role of intramolecular disulfide bonds in enzyme catalysis.
    Lo JY; Smith LC; Chan L
    Biochem Biophys Res Commun; 1995 Jan; 206(1):266-71. PubMed ID: 7818530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of CD45. A leukocyte-specific protein tyrosine phosphatase.
    Johnson P; Ostergaard HL; Wasden C; Trowbridge IS
    J Biol Chem; 1992 Apr; 267(12):8035-41. PubMed ID: 1314815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable interdomain interaction within the cytoplasmic domain of CD45 increases enzyme stability.
    Felberg J; Johnson P
    Biochem Biophys Res Commun; 2000 May; 271(2):292-8. PubMed ID: 10799290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CD45 in adhesion and suppression of apoptosis of mouse malignant T-lymphoma cells.
    Hanaoka K; Fujita N; Lee SH; Seimiya H; Naito M; Tsuruo T
    Cancer Res; 1995 May; 55(10):2186-90. PubMed ID: 7743522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.